⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 31, 2024Anticancer Research

Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer

Satoshi Ano Norihiro Kikuchi Shinichiro Okauchi Takeshi Numata RYOTA NAKAMURA Toshihiro Shiozawa Hiroko Watanabe TOMOHIRO TAMURA Kunihiko Miyazaki SHIGEN HAYASHI TAKAAKI YAMASHITA KOICHI KURISHIMA MASAHARU INAGAKI Takayuki Kaburagi Takeo Endo Hiroaki Satoh NOBUYUKI HIZAWA

View at Publisher

Ask AI

Bookmark

Share

Abstract

Atezolizumab, an anti-PD-L1 antibody, has been increasingly administered in combination with chemotherapy to patients with small cell lung cancer (SCLC). This study aimed to determine how patients with extensive disease (ED) -SCLC responded to atezolizumab with chemotherapy and found factors affecting long-term response and survival.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ano et al. (2024) studied this question.

synapsesocial.com/papers/68e6762bb6db64358760083c https://doi.org/10.21873/anticanres.17080

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The outcomes of atezolizumab therapy in combination with carboplatin and etoposide for small-cell lung cancer.2024
2Results of the use of immune checkpoint inhibitors in the treatment of small cell lung cancer in real-life clinical practice: results of a single-center observational study2025 · 1 citations
3First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerRCT · 2018 · 3,566 citations
4Effectiveness of Atezolizumab in Addition to Chemotherapy in ES-SCLC: A Retrospective Real-World Monocentric Study2025 · 5 citations
5Efficacy of atezolizumab in combination with carboplatin and etoposide in first-line therapy for advanced small cell lung cancer in real clinical practice: a retrospective single-center studyCohort Study · 2026

More related papers

Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival: A Case Report2024
Real-world efficacy of atezolizumab combined with etoposide and platinum chemotherapy in extensive-stage small cell lung cancer: a retrospective cohort study2025
A Real-World Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive Stage Small Cell Lung Cancer2024

More from Anticancer Research

Evaluation of Pirfenidone as a Novel Radioprotectant for Radiation-induced Intestinal InjuryThu,
Prognostic Significance of PET− SUV max in Patients Undergoing Resection of Hepatocellular Carcinoma >3 cm: A Retrospective AnalysisThu,